LifeCell, pioneers in stem cell banking and research, has created yet another landmark in the industry with 5000 enrolments from across India and overseas in 2 years.

The strategic initiatives adopted and implemented by LifeCell have resulted in an overwhelming response for its services in stem cell banking. Launched in November 2004, LifeCell is India's first private cord blood bank to bring the revolutionary medical breakthrough of umbilical cord stem cell banking to the country.

Currently, LifeCell has 25 marketing and collection centres in India as well as in the international market. The company has received a phenomenal response and recorded maximum enrolments from New Delhi and Mumbai followed by centres in South India namely, Chennai Bangalore and Hyderabad.

LifeCell has also entered into strategic association with various institutions in an effort to offer families a bio-insurance for stem cell based therapeutic applications in future. The company has an alliance with Saneron CCEL Therapeutics for clinical trials and is also set to launch their exclusive stem cell therapy centre in association with Sri Ramachandra Medical College and Research Institute, at Chennai for Haematological and Oncological ailments. This exclusive stem cell therapy centre will start operations by March 2007.

Chandra Mouli, CEO, LifeCell, said, "LifeCell provides its customers with the highest ascribed quality, innovative and most affordable cord blood stem cell banking service available in today's market. Over 5,000 expectant parents from all corners of the country have enrolled with us. We are pleased that our sustained efforts on educating the medical fraternity and the expectant parents on the advantages of banking their child's cord blood stem cells have paid off and LifeCell has made enormous progress in just 2 years and based on this momentum we are hoping to enrol over 10,000 member next financial year."

As a part of LifeCell's commitment to create a world-class stem cell organisation and offer the benefits of stem cell technology to the people, LifeCell has invited many experts on its Scientific Advisory Board. The company has been awarded ISO 9001:2000 Certification and is applied for accreditation by American Association of Blood Banks (AABB) and US FDA.

Cord blood, which is discarded after childbirth, is a rich source of stem cells. These stem cells can be harvested and cryo preserved to be used for treating more than 75 serious ailments including neurological disorders and cardiac conditions. LifeCell offers its services for a fixed and transparent price. The cost includes an enrolment fee of Rs 5000, Processing fee: Rs 32,600 and an annual storage fee: Rs 3,500. One time payment option of Rs.75,500 is also available.